• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
JOIN or RENEW HERE
✕
Categories
  • Primary Sclerosing Cholangitis
Tags
  • Primary Sclerosing Cholangitis
Study title A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) (VISTAS)
Disease or condition Primary sclerosing cholangitis
Study type Interventional  (Clinical Trial)
Intervention/treatment Volixibat
Phase 2
Study site Duke University
Study location Durham
Principal investigator name and email Julius Wilder, MD PHD
Study coordinator name and email Adele Gaskin, adele.gaskin@duke.edu
Phone contact 919-684-0742 
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/record/NCT04950127

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE